Leukocyte emigration from the vasculature is dependent on receptor/counterreceptor pairs expressed on leukocytes and endothelial cells. Initial rolling of leukocytes on the endothelium, which occurs before firm attachment and migration, is governed by the selectins [I] . Functional counterreceptors for the selectins possess fucosylated structures from the Lewis blood group system [2, 31. Mouse 'knock-out' experiments to study a 1,3 fucosyltransferases (FucT's) have demonstrated the importance of FucTVII in the synthesis of selectin ligands on the surface of both leukocytes and endothelial cells [4]. The failure of FucTVII deficient leukocytes to express sialyl Lewis X (sLeX) severely effects their ability to migrate from the vasculature into the tissues during an inflammatory response. The tissue distribution of FucTVII is similar between mouse and man, suggesting that FucTVII is required for selectin ligand formation in man. In order to provide sufficient FucTVII for extensive functional studies, we have expressed a secreted, truncated and affinity tagged form of the The coding sequence for FucTVII was cloned as previously described [5] by reverse tramdptase polymerase chain reaction (RT-PCR) using cDNA from the human cell line HL60. A nucleotide sequence for FucTVII with no transmembrane or cytoplasmic domains was generated by PCR. This was done using a 5' sense oligonucleotide primer homologous to the sequence immediately downstream of the transmembrane domain and a 3' antisense primer traversing the termination codon.
A fusion partner for the truncated enzyme was generated again by PCR, using the plasmid pLA-ZZ-E-sel (kindly provided by Comparison of acceptor specificity of the secreted, truncated and the full length forms of FucTVII expressed in insect cells. Enzyme activity was measured as described by Zollner and Vestweber (1996) [6] . Preference for the transfer of 3~-f u c~~ from GDP-~UC~X to three different saccharide Bcceptors was determined for both FucTVII enzymes. Activity for each enzyme was plotted as a percentage of the activity seen with 3'SLN, the favoured acceptor for full length FucTVII.
the truncated enzyme and the Z-cassette were ligated together and sub-cloned into the baculovirus transfer vector pVL1392 at an MOI of I to 2. Approximately 90% of the activity from the FucTVII fusion protein (Z-FucTVII) was secreted into the medium (specific activity 150 pmol/min/mg) and 10% remained in the cell pellet. Secreted Z-FucTVII was purified by binding to IgG-sepharose for 18h at 4'C, washing extensively with 50mM Tris-C1 pH 7.6 and eluting in 250mM acetate pH 3.4. To retain activity, the enzyme was eluted directly into 2M Tris-CI pH7.6 containing 0.3% BSA. SDS-PAGE analysis of the purified enzyme showed a protein band of approximately 60kDa and was confirmed to be Z-FucTVII by Nterminal amino acid sequence analysis. The yield of active enzyme was optimised to Zmg/litre and purification gave a 70% recovery with an increase in specific activity of approximately 80 fold. Fig 2 shows the acceptor requirement and NEM sensitivity of Z-FucTVII in comparison to the full length enzyme. The activities of the two enzymes were identical showing that the truncated enzyme possesses 'wild-type' FucTVII characteristics.
In conclusion, we have demonstrated large scale expression (up to 50 litres) and purification of a secreted, active form of human FwTVII.
